» Articles » PMID: 36803548

MYC Promotes Fibroblast Osteogenesis by Regulating ALP and BMP2 to Participate in Ectopic Ossification of Ankylosing Spondylitis

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2023 Feb 21
PMID 36803548
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ectopic ossification is an important cause of disability in patients with ankylosing spondylitis (AS). Whether fibroblasts can transdifferentiate into osteoblasts and contribute to ossification remains unknown. This study aims to investigate the role of stem cell transcription factors (POU5F1, SOX2, KLF4, MYC, etc.) of fibroblasts in ectopic ossification in patients with AS.

Methods: Primary fibroblasts were isolated from the ligaments of patients with AS or osteoarthritis (OA). In an in vitro study, primary fibroblasts were cultured in osteogenic differentiation medium (ODM) to induce ossification. The level of mineralization was assessed by mineralization assay. The mRNA and protein levels of stem cell transcription factors were measured by real-time quantitative PCR (q-PCR) and western blotting. MYC was knocked down by infecting primary fibroblasts with lentivirus. The interactions between stem cell transcription factors and osteogenic genes were analysed by chromatin immunoprecipitation (ChIP). Recombinant human cytokines were added to the osteogenic model in vitro to evaluate their role in ossification.

Results: We found that MYC was elevated significantly in the process of inducing primary fibroblasts to differentiate into osteoblasts. In addition, the level of MYC was remarkably higher in AS ligaments than in OA ligaments. When MYC was knocked down, the expression of the osteogenic genes alkaline phosphatase (ALP) and bone morphogenic protein 2 (BMP2) was decreased, and the level of mineralization was reduced significantly. In addition, the ALP and BMP2 were confirmed to be the direct target genes of MYC. Furthermore, interferon-γ (IFN-γ), which showed high expression in AS ligaments, was found to promote the expression of MYC in fibroblasts in the process of ossification in vitro.

Conclusions: This study demonstrates the role of MYC in ectopic ossification. MYC may act as the critical bridge that links inflammation with ossification in AS, thus providing new insights into the molecular mechanisms of ectopic ossification in AS.

Citing Articles

The effect of IGF-1 on cartilage injury in bone marrow mesenchymal stem cells through the BMP2-Smad1/5 signaling pathway.

Ye H, Shao L In Vitro Cell Dev Biol Anim. 2025; .

PMID: 40045149 DOI: 10.1007/s11626-025-01015-4.


Fibroblasts in heterotopic ossification: mechanisms and therapeutic targets.

Li J, Dang Y, Liu M, Gao L, Lin H Int J Biol Sci. 2025; 21(2):544-564.

PMID: 39781450 PMC: 11705629. DOI: 10.7150/ijbs.102297.


Exosomal miR-590-3p derived from bone marrow mesenchymal stem cells promotes osteoblast differentiation and osteogenesis by targeting TGFBR1.

Luo D, Xie W, He X, Zhou X, Ye P, Wang P In Vitro Cell Dev Biol Anim. 2024; 61(1):46-58.

PMID: 39560913 DOI: 10.1007/s11626-024-00985-1.


MYC: there is more to it than cancer.

Zacarias-Fluck M, Soucek L, Whitfield J Front Cell Dev Biol. 2024; 12:1342872.

PMID: 38510176 PMC: 10952043. DOI: 10.3389/fcell.2024.1342872.


Single-cell sequencing and transcriptome analyses in the construction of a liquid-liquid phase separation-associated gene model for rheumatoid arthritis.

Tai J, Wang L, Yan Z, Liu J Front Genet. 2023; 14:1210722.

PMID: 37953920 PMC: 10634374. DOI: 10.3389/fgene.2023.1210722.

References
1.
Klavdianou K, Tsiami S, Baraliakos X . New developments in ankylosing spondylitis-status in 2021. Rheumatology (Oxford). 2021; 60(Suppl 6):vi29-vi37. PMC: 8709566. DOI: 10.1093/rheumatology/keab523. View

2.
Xu Z, Chen D, Hu Y, Jiang K, Huang H, Du Y . Anatomically distinct fibroblast subsets determine skin autoimmune patterns. Nature. 2021; 601(7891):118-124. DOI: 10.1038/s41586-021-04221-8. View

3.
Papagoras C, Chrysanthopoulou A, Mitsios A, Ntinopoulou M, Tsironidou V, Batsali A . IL-17A expressed on neutrophil extracellular traps promotes mesenchymal stem cell differentiation toward bone-forming cells in ankylosing spondylitis. Eur J Immunol. 2020; 51(4):930-942. DOI: 10.1002/eji.202048878. View

4.
Zou Y, Yang X, Yuan S, Zhang P, Ye Y, Li Y . Downregulation of dickkopf-1 enhances the proliferation and osteogenic potential of fibroblasts isolated from ankylosing spondylitis patients via the Wnt/β-catenin signaling pathway in vitro. Connect Tissue Res. 2016; 57(3):200-11. DOI: 10.3109/03008207.2015.1127916. View

5.
Fert I, Cagnard N, Glatigny S, Letourneur F, Jacques S, Smith J . Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis. Arthritis Rheumatol. 2014; 66(4):841-51. PMC: 4226235. DOI: 10.1002/art.38318. View